SCHEMBL22728323

SCHEMBL22728323

N#CC1(Cc2cccc(C(F)(F)F)c2)CCN(C(=S)c2cccnc2-c2ccncn2)CC1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CYP46A1 Q9Y6A2 5/20 0.47
▸ PKLR P30613 1/20 0.37
▸ CYP3A4 P08684 2/20 0.34
▸ CYP2C19 P33261 2/20 0.34
▸ CYP2C8 P10632 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ GPR52 Q9Y2T5 2/20 0.33
▸ KDR P35968 2/20 0.33
▸ TEK Q02763 2/20 0.33
▸ GAA P10253 1/20 0.33
▸ PHGDH O43175 2/20 0.33
▸ ELANE P08246 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ NAMPT P43490 1/20 0.32
▸ LCK P06239 1/20 0.32
▸ BRAF P15056 1/20 0.32
▸ MAPK14 Q16539 1/20 0.32
▸ RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29453798 0.91 CYP46A1 (0.59) CYP46A1PKLRCYP3A4CYP2C19CYP2C8
SCHEMBL22719439 0.91 CYP46A1 (0.59) CYP46A1PKLRCYP3A4CYP2C19CYP2C8
SCHEMBL22719352 0.82 CYP46A1 (0.61) CYP46A1CYP3A4CYP2C19CYP2C8CYP2C9
SCHEMBL29453788 0.82 CYP46A1 (0.61) CYP46A1CYP3A4CYP2C19CYP2C8CYP2C9
SCHEMBL22728370 0.80 CYP46A1 (0.44) CYP46A1PKLRCYP3A4CYP2C19CYP2C8
SCHEMBL29453812 0.80 CYP46A1 (0.57) CYP46A1PKLRCYP3A4CYP2C19CYP2C8
SCHEMBL22719411 0.80 CYP46A1 (0.57) CYP46A1PKLRCYP3A4CYP2C19CYP2C8
SCHEMBL29453644 0.79 CYP46A1 (0.55) CYP46A1CYP3A4CYP2C19CYP2C8CYP2C9
SCHEMBL22719329 0.79 CYP46A1 (0.55) CYP46A1CYP3A4CYP2C19CYP2C8CYP2C9
SCHEMBL22719371 0.78 CYP46A1 (0.55) CYP46A1PKLRCYP3A4CYP2C19CYP2C8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020243027-A1 COMPOUNDS, COMPOSITIONS, AND METHODS OF USE SAGE THERAPEUTICS, INC. (US) 2020-12-03 — — WO disclosed
Send feedback